Core Viewpoint - The Hong Kong Innovative Drug 50 ETF (513780) experienced a slight decline of 0.29% on December 1, with a trading volume of 285 million yuan, indicating a decrease in investor interest and market activity [1] Fund Performance - The fund's latest net asset value is calculated at 2.992 billion yuan, with a total share count of 1.732 billion, reflecting a reduction of 14 million shares on the day and a total decrease of 81.5 million shares over the past 20 trading days [1] - Since its inception on October 16, 2024, the fund has achieved a return of 72.76%, while the return over the past month has been -0.86% [1] Management Information - The fund is managed by Invesco Great Wall Fund Management Co., Ltd., with Jin Huang serving as the fund manager [1]
12月1日港股创新药50ETF（513780）份额减少1400.00万份，最新份额17.32亿份，最新规模29.92亿元
Xin Lang Cai Jing·2025-12-02 02:59